Alivus Life Sciences Ltd.

Net sales declined -6.67%  to  Rs. 4898.70 million from Rs. 5248.97 millions.A slim rise of 7.75% was recorded in the Net profit for the quarter ended June 2022 to Rs. 1087.33  millions  From Rs. 1009.13 millions.The company reported a degrowth in operating Profit to 1562.61 millions from 1644.34 millions.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202206	202106	% Var	202206	202106	% Var	202203	202103	% Var
Sales	4898.70	5248.97	-6.67	4898.70	5248.97	-6.67	21232.14	18851.65	12.63
Other Income	94.93	39.86	138.16	94.93	39.86	138.16	147.04	8.11	1713.07
PBIDT	1562.61	1644.34	-4.97	1562.61	1644.34	-4.97	6307.64	5918.85	6.57
Interest	1.35	205.50	-99.34	1.35	205.50	-99.34	279.62	875.47	-68.06
PBDT	1561.26	1438.84	8.51	1561.26	1438.84	8.51	6028.02	5043.38	19.52
Depreciation	98.79	89.19	10.76	98.79	89.19	10.76	378.77	333.94	13.42
PBT	1462.47	1349.65	8.36	1462.47	1349.65	8.36	5649.25	4709.44	19.96
TAX	375.14	340.52	10.17	375.14	340.52	10.17	1462.01	1193.63	22.48
Deferred Tax	12.85	18.09	-28.97	12.85	18.09	-28.97	85.74	66.17	29.58
PAT	1087.33	1009.13	7.75	1087.33	1009.13	7.75	4187.24	3515.81	19.10
Equity	245.05	215.61	13.65	245.05	215.61	13.65	245.05	19.60	1150.26
PBIDTM(%)	31.90	31.33	1.82	31.90	31.33	1.82	29.71	31.40	-5.38